One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Access
PDF Availablehttps://doi.org/10.1182/blood-2021-146175
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 5, 2021 |
 Citations: 10 |
Affiliation: The University of Texas MD Anderson Cancer Center, University of Michigan–Ann Arbor, Michigan Center for Translational Pathology, St. Eugenio Hospital, Moffitt Cancer Center, Washington University in St. Louis, Singapore General Hospital, Duke-NUS Medical School, Memorial Sloan Kettering Cancer Center, Takeda (United States), Princess Margaret Cancer Centre, Dana-Farber Cancer Institute, Hôpital Lyon Sud, University of Utah, Huntsman Cancer Institute, Centre Hospitalier de Versailles, Versailles Saint-Quentin-en-Yvelines University, Jena University Hospital, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Istituti di Ricovero e Cura a Carattere Scientifico, Hôpital Saint-Louis, Imperial College London, Augusta University Health, University of California, San Francisco
Dose Modification Dynamics of Ponatinib in Patients with Chronic-Phase Chronic Myeloid Leukemia (CP-CML) from the PACE and Optic Trials
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
